Skip to main content
. 2021 Oct 19;9(10):1498. doi: 10.3390/biomedicines9101498

Figure 5.

Figure 5

The implication of mTORC2/RICTOR in the resistance of melanoma to targeted therapies in cells grown as spheroids. (A,B) A375 parental and resistant cell lines were grown as spheroids and treated with DMSO, Vemurafenib (10 μM), OSI-027 (3 μM), or the combination of both for 10 days and counted. Pictures were taken after 10 days of treatment; scale bar represents 1000 μm. Graphs represent the mean ± s.d. of an experiment in triplicate (similar results were obtained in three independent experiments).